Home News and Analysis Deals & Exits Immunitas Therapeutics nets $39 mln Series A Return to search News and Analysis Immunitas Therapeutics nets $39 mln Series A Iris Dorbian - 22 November 2019 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in